A disease network-based deep learning approach for characterizing melanoma.

Abstract

Multiple types of genomic variations are present in cutaneous melanoma and some of the genomic features may have an impact on the prognosis of the disease. The access to genomics data via public repositories such as The Cancer Genome Atlas (TCGA) allows for a better understanding of melanoma at the molecular level, therefore making characterization of substantial heterogeneity in melanoma patients possible. Here, we proposed an approach that integrates genomics data, a disease network, and a deep learning model to classify melanoma patients for prognosis, assess the impact of genomic features on the classification and provide interpretation to the impactful features. We integrated genomics data into a melanoma network and applied an autoencoder model to identify subgroups in TCGA melanoma patients. The model utilizes communities identified in the network to effectively reduce the dimensionality of genomics data into a patient score profile. Based on the score profile, we identified three patient subtypes that show different survival times. Furthermore, we quantified and ranked the impact of genomic features on the patient score profile using a machine-learning technique. Follow-up analysis of the top-ranking features provided us with the biological interpretation of them at both pathway and molecular levels, such as their mutation and interactome profiles in melanoma and their involvement in pathways associated with signaling transduction, immune system and cell cycle. Taken together, we demonstrated the ability of the approach to identify disease subgroups using a deep learning model that captures the most relevant information of genomics data in the melanoma network.

• Authors: Xin Lai, Jinfei Zhou, Anja Wessely, Markus Heppt, Andreas Maier, Carola Berking, Julio Vera, Le Zhang
• Journal: International journal of cancer (Int J Cancer) Vol. 150 Issue 6 Pg. 1029-1044 (Mar 15 2022) ISSN: 1097-0215 [Electronic] United States
• PMID: 34716589 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2021 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Chemical References

• ERBB3 protein, human
• Receptor, ErbB-3
• Matrix Metalloproteinase 2

Topics

• Adult
• Aged
• Deep Learning
• Female
• Genomics
• Humans
• Male
• Matrix Metalloproteinase 2 (genetics)
• Melanoma (genetics)
• Middle Aged
• Receptor, ErbB-3 (genetics)
• Signal Transduction
• Skin Neoplasms (genetics)
• Young Adult